Do Multigene Panels Offer Cancer Patients, Payers More Value?

Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....
Read More

Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk

Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...
Read More

Bridging the Gap Between the Clinical Possibilities and Economics of Precision Medicine

From research and development to pricing and access, the discourse on precision medicine is expanding, reflecting the emergence of new and multiple ideas of precision medicine aims in relation to healthcare economics, payment models, and patient outcomes...
Read More

Considering Risks and Privacy in Genetic Medicine: Q&A with Dr. Paul S. Appelbaum

Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information...
Read More

How Healthcare Organizations Can Drive Diversity in Genetic Research

Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs...
Read More

The Case for Precision Medicine in Primary Care

Pioneer in precision prevention explains the shift to precision medicine in primary care, and the work of Sanford Imagenetics in creating precision medicine modules for physicians...
Read More

3 Steps to Make Precision Medicine Part of the Medical Culture

Walking the fine line between not being the biggest risk taker and not being the last adopter, hospitals that offer genetic testing can expect their market share to increase and their payer mix to improve, according to LSUHSC’s Miele...
Read More

Managing and Maximizing the Volumes of Data Coming from Genomic Analysis

Lori Anderson of XIFIN to share views on the current state of informatics in precision medicine as well as challenges and future trends for this field...
Read More

How to Get Payers and Providers on the Same Page with Genetic Testing Reimbursement

Michael Astion, MD, PhD, to share how the philosophy of the “two rights” can drive alignment and compromise among payers, providers, and patients...
Read More